AJP - Gastrointestinal and Liver Physiology, Vol 271, Issue 5 780-G790, Copyright © 1996 by American Physiological Society

ARTICLES

Differential regulation of hepatocyte DNA synthesis by cAMP in vitro in vivo

J. K. Westwick, J. Fleckenstein, M. Yin, S. Q. Yang, C. A. Bradham, D. A. Brenner and A. M. Diehl
Department of Pharmacology, University of North Carolina, Chapel Hill 27599, USA.

Adenosine 3',5'-cyclic monophosphate (cAMP) prevents epidermal growth factor (EGF)-induced DNA synthesis in many types of cultured cells, including hepatocytes, but its effects on cellular proliferation in vivo are unknown. This study compares the effects of supplemental cAMP on hepatocyte proliferation induced in vivo by 70% partial hepatectomy (PH) and in vitro by EGF and determines the effects of cAMP on AP-1, a family of growth-regulatory transcription factors, and the kinase cascades that normally activate AP-1. Although injection of dibutyryladenosine 3',5'-cyclic monophosphate (30 mg/kgip) at the time of PH increased liver cAMP concentrations at least 100-fold for several hours, it did not inhibit hepatic incorporation of [3H]thymidine or proliferating cell nuclear antigen expression 24 h after PH. cAMP treatment led to a complete inhibition of extracellular signal-related kinase (ERK) activity and transiently reduced NH2-terminal Jun nuclear kinase (JNK) activity after PH but did not decrease the expression of c-jun mRNA or protein. Consistent with the known cAMP stimulation of jun-B in cultured cells, cAMP treatment increased jun-B mRNA, protein, and DNA binding activity post-PH. Surprisingly, cAMP treatment enhanced Raf kinase activity after PH in rats. In primary hepatocyte cultures, supplemental cAMP inhibited JNK and ERK activity, total AP-1 and c-Jun transcriptional activities, and DNA synthesis. Thus elevated cAMP inhibited ERK and JNK activity in culture and in vivo and inhibited hepatocyte proliferation in culture but not in vivo. This suggests that in vivo mechanisms compensate for cAMP inhibition of certain growth-related signaling cascades and emphasizes potential risks of extrapolating from simple cell culture systems to explain physiology in intact animals.

This article has been cited by other articles:

				C. A. Bradham, E. Hatano, and D. A. Brenner Dominant-negative TAK1 induces c-Myc and G0 exit in liver Am J Physiol Gastrointest Liver Physiol, November 1, 2001; 281(5): G1279 - G1289. [Abstract] [Full Text] [PDF]

				C. Rescan, A. Coutant, H. Talarmin, N. Theret, D. Glaise, C. Guguen-Guillouzo, and G. Baffet Mechanism in the Sequential Control of Cell Morphology and S Phase Entry by Epidermal Growth Factor Involves Distinct MEK/ERK Activations Mol. Biol. Cell, March 1, 2001; 12(3): 725 - 738. [Abstract] [Full Text]

				H. Talarmin, C. Rescan, S. Cariou, D. Glaise, G. Zanninelli, M. Bilodeau, P. Loyer, C. Guguen-Guillouzo, and G. Baffet The Mitogen-Activated Protein Kinase Kinase/Extracellular Signal-Regulated Kinase Cascade Activation Is a Key Signalling Pathway Involved in the Regulation of G1 Phase Progression in Proliferating Hepatocytes Mol. Cell. Biol., September 1, 1999; 19(9): 6003 - 6011. [Abstract] [Full Text] [PDF]